Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Reference13 articles.
1. Frieder J, Kivelevitch D, Menter A (2018) Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis. Ther Adv Chronic Dis 9(1):5–21. https://doi.org/10.1177/2040622317738910
2. Koenders MI, van den Berg WB (2016) Secukinumab for rheumatology: development and its potential place in therapy. Drug Des Devel Ther 10:2069–2080. https://doi.org/10.2147/DDDT.S105263
3. Ritchlin CT, Colbert RA, Gladman DD (2017) Psoriatic arthritis. N Engl J Med 376:957–970. https://doi.org/10.1056/NEJMra1505557
4. Armstrong AW, Papp K, Kircik L. Secukinumab (2016) Review of clinical evidence from the pivotal studies ERASURE, FIXTURE, and CLEAR. J Clin Aesthet Dermatol9(6 Suppl 1):S7-S12
5. Armstrong AW, Vender R, Kircik L (2016) Secukinumab in the treatment of palmoplantar, nail, scalp, and pustular psoriasis. J Clin Aesthet Dermatol 9(6 Suppl 1):S12–S16
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献